0001477932-21-000061.txt : 20210106 0001477932-21-000061.hdr.sgml : 20210106 20210106123001 ACCESSION NUMBER: 0001477932-21-000061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210106 DATE AS OF CHANGE: 20210106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heaton Kristofer CENTRAL INDEX KEY: 0001835114 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27781 FILM NUMBER: 21509643 MAIL ADDRESS: STREET 1: 10624 SOUTH EASTERN AVE. STREET 2: SUITE A209 CITY: HENDERSON STATE: NV ZIP: 89052 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: United Health Products, Inc. CENTRAL INDEX KEY: 0001096938 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 841517723 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10624 S. EASTERN AVE STREET 2: STE. A209 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: (877) 358-3444 MAIL ADDRESS: STREET 1: 10624 S. EASTERN AVE STREET 2: STE. A209 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: United EcoEnergy Corp. DATE OF NAME CHANGE: 20060224 FORMER COMPANY: FORMER CONFORMED NAME: MNS EAGLE EQUITY GROUP III INC DATE OF NAME CHANGE: 19991019 4 1 form4.xml FORM 4 X0306 4 2020-12-31-05:00 false 0001096938 United Health Products, Inc. UEEC 0001835114 Heaton Kristofer 10624 SOUTH EASTERN AVE. SUITE A209 HENDERSON NV 89052 false true false false Principal Financial Officer Restricted Stock Unit Awards 2020-12-31-05:00 4 A false 500000 A Common Stock 500000 925000 D In December 2020, Mr. Heaton was granted 500,000 restricted stock unit awards ("RSUs") bringing his total to 925,000. The new 500,000 restricted stock unit awards vest upon performance and do not contain a conversion or exercise price or any time constraints. 5% of the RSUs vest upon FDA approval of the company's Class III PMA, an additional 10% of the RSUs will vest upon the execution of each commercial distribution agreement from the marketing of its products, up to a maximum of three such agreements and the balance will vest upon the company achieving $30 million in gross cumulative sales or a covered transaction as defined in the agreement. Prior to December 2020 and prior to Mr. Heaton becoming VP-Finance, Mr. Heaton was granted 500,000 RSUs, which included 75,000 which vested in July 2020. An additional 75,000 RSUs vest upon FDA approval of the Company's Class III PMA, an additional 100,000 RSUs will vest on January 1, 2021 and the balance will vest upon the Company achieving $20,000,000 in gross cumulative sales or a covered transaction or a trigger event as defined in the agreement. Not applicable. /s/ Kristofer Heaton 2021-01-06-05:00